217 related articles for article (PubMed ID: 6104634)
1. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634
[TBL] [Abstract][Full Text] [Related]
2. Studies on a new beta-receptor blocking drug, tobanum--1-(2,5-dichlorophenoxy)-3-tertiary-butylamino-2-propanol HCl: its use in cardiovascular hyperkinetic syndrome, hypertension, and angina pectoris, and its effect on respiration.
Szám I; Büky P; Gulyás A; Sinkovics M
Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):128-33. PubMed ID: 6121761
[TBL] [Abstract][Full Text] [Related]
3. [Haemodynamic characterization of a new beta-receptor blocker celiprolol (st1396) at rest and during ergometer exercise compared with propranolol (inderal) (author's transl)].
Bonelli J; Magometschnigg D; Hitzenberger G; Kaik G
Wien Klin Wochenschr; 1978 May; 90(10):350-4. PubMed ID: 26139
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of the beta-blocker chlorpropanol (tobanum) in hypertension patients].
Sirakova V; Penkov N; Kaponov Kh
Vutr Boles; 1986; 25(1):35-41. PubMed ID: 2872751
[TBL] [Abstract][Full Text] [Related]
5. Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparision with propranolol.
Frick MH; Hartikainen M; Pörsti P
Ann Clin Res; 1978 Apr; 10(2):105-6. PubMed ID: 28071
[TBL] [Abstract][Full Text] [Related]
6. Beta-adrenergic blocking therapy in hypertension: selection of patients.
Frohlich ED; Tarazi RC; Dustan HP
Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):151-6. PubMed ID: 4395481
[No Abstract] [Full Text] [Related]
7. Comparison of the antihypertensive effects of celiprolol and enalapril.
Ghiringhelli S; Cozzi E; Tsialtas D
J Int Med Res; 1988; 16 Suppl 1():73A-79A. PubMed ID: 2906019
[TBL] [Abstract][Full Text] [Related]
8. [Haemodynamic response to antihypertensive treatment with atenolol in patients with hypertension (author's transl].
Zilcher H; Glogar D; Uhlir H; Leisch F; Niederberger M; Steinbach K
Wien Klin Wochenschr; 1978 Sep; 90(16):611-6. PubMed ID: 695651
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of various parameters for the antihypertensive effect of the beta blocker ICI 66,082 (1).
Meekers J; Missotten A; Fagard R; Demuynck D; Harvengt C; Pas P; Billiet L; Amery A
Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):294-306. PubMed ID: 238480
[TBL] [Abstract][Full Text] [Related]
10. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the haemodynamic effects in man of the beta-adrenergic blocking substances Kö 1366 and practolol (author's transl)].
Gloger K
Arzneimittelforschung; 1975 Aug; 25(8):1300-3. PubMed ID: 241365
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of the effect of obsidan in essential hypertension patients with different types of circulation].
Goloshchapov OA; Pribylova NN; Kotova LN; Nozhnova LP
Ter Arkh; 1986; 58(11):29-32. PubMed ID: 3824185
[TBL] [Abstract][Full Text] [Related]
13. [Effect of celiprolol compared to propranolol on thyroid metabolism].
Langsteger W; Lind P; Eber O
Wien Med Wochenschr; 1985 Sep; 135(18):451-7. PubMed ID: 2865857
[TBL] [Abstract][Full Text] [Related]
14. [Effects of the new adrenergic beta receptor blockader Kö 1366 (Bunitrolol) on blood circulation].
Klempt HW; Bender F
Arzneimittelforschung; 1973 Aug; 23(8):1064-70. PubMed ID: 4148873
[No Abstract] [Full Text] [Related]
15. [The effect of Tobanum (GYKI-41099) in essential circulatory hyperkinesis, studied by radiocardiography].
Józan M; Tarján J; Wágner G; Rostás L; Lascsik L; Kovács S; Parti G
Orv Hetil; 1981 Oct; 122(41):2547-8. PubMed ID: 6119668
[No Abstract] [Full Text] [Related]
16. [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
Dorow P
Arzneimittelforschung; 1987 Dec; 37(12):1370-2. PubMed ID: 2896506
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of adrenergic beta-receptor blocking agents.
Sannerstedt R
Adv Clin Pharmacol; 1976; 11():70-8. PubMed ID: 25571
[No Abstract] [Full Text] [Related]
18. [Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
Ambrosioni E; Bracchetti D; Russo F; Catizone L; Perri G; Magnani B
Boll Soc Ital Cardiol; 1972; 17(2):91-101. PubMed ID: 4403643
[No Abstract] [Full Text] [Related]
19. Propranolol and renal hemodynamics at rest and during exercise.
Malini PL; Strocchi E; Ambrosioni E
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):611-4. PubMed ID: 6668099
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and adrenergic responses of bevantolol and propranolol in hypertensives.
Snedden W; Fernandez PG; Vasdev S; Bolli P
Can J Cardiol; 1989; 5(1):37-41. PubMed ID: 2563955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
